CN113413332A - 一种具有美白抗氧化和修复功能的御米油脂质体 - Google Patents
一种具有美白抗氧化和修复功能的御米油脂质体 Download PDFInfo
- Publication number
- CN113413332A CN113413332A CN202110647996.5A CN202110647996A CN113413332A CN 113413332 A CN113413332 A CN 113413332A CN 202110647996 A CN202110647996 A CN 202110647996A CN 113413332 A CN113413332 A CN 113413332A
- Authority
- CN
- China
- Prior art keywords
- rice oil
- liposome
- parts
- oil liposome
- whitening
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000007164 Oryza sativa Nutrition 0.000 title claims abstract description 91
- 235000009566 rice Nutrition 0.000 title claims abstract description 91
- 239000002502 liposome Substances 0.000 title claims abstract description 81
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 19
- 230000002087 whitening effect Effects 0.000 title claims abstract description 18
- 230000006870 function Effects 0.000 title claims abstract description 17
- 239000003963 antioxidant agent Substances 0.000 title claims abstract description 15
- 240000007594 Oryza sativa Species 0.000 title 1
- 241000209094 Oryza Species 0.000 claims abstract description 90
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 50
- 238000002360 preparation method Methods 0.000 claims abstract description 28
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000006071 cream Substances 0.000 claims abstract description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000002537 cosmetic Substances 0.000 claims abstract description 16
- 229930182494 ginsenoside Natural products 0.000 claims abstract description 16
- 229940119217 chamomile extract Drugs 0.000 claims abstract description 15
- 235000020221 chamomile extract Nutrition 0.000 claims abstract description 15
- 229940089161 ginsenoside Drugs 0.000 claims abstract description 15
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000006708 antioxidants Nutrition 0.000 claims abstract description 14
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 12
- 235000010445 lecithin Nutrition 0.000 claims abstract description 12
- 239000000787 lecithin Substances 0.000 claims abstract description 12
- 229940067606 lecithin Drugs 0.000 claims abstract description 12
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims abstract description 11
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims abstract description 11
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims abstract description 11
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 9
- 244000269722 Thea sinensis Species 0.000 claims abstract description 9
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 9
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 9
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 9
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 9
- 239000000230 xanthan gum Substances 0.000 claims abstract description 9
- 235000010493 xanthan gum Nutrition 0.000 claims abstract description 9
- 229920001285 xanthan gum Polymers 0.000 claims abstract description 9
- 229940082509 xanthan gum Drugs 0.000 claims abstract description 9
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000000661 sodium alginate Substances 0.000 claims abstract description 8
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 8
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 8
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000004288 Sodium dehydroacetate Substances 0.000 claims abstract description 7
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 7
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229960005323 phenoxyethanol Drugs 0.000 claims abstract description 7
- 229940079839 sodium dehydroacetate Drugs 0.000 claims abstract description 7
- 235000019259 sodium dehydroacetate Nutrition 0.000 claims abstract description 7
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 claims abstract description 7
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 7
- 229940046009 vitamin E Drugs 0.000 claims abstract description 7
- 239000011709 vitamin E Substances 0.000 claims abstract description 7
- 235000011187 glycerol Nutrition 0.000 claims abstract description 6
- 239000000203 mixture Substances 0.000 claims abstract description 6
- -1 eye patch Substances 0.000 claims abstract description 5
- 230000001815 facial effect Effects 0.000 claims abstract description 3
- 229960005150 glycerol Drugs 0.000 claims abstract description 3
- 239000006210 lotion Substances 0.000 claims abstract description 3
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims abstract description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims abstract description 3
- 229940068968 polysorbate 80 Drugs 0.000 claims abstract description 3
- 229920000053 polysorbate 80 Polymers 0.000 claims abstract description 3
- 229960004063 propylene glycol Drugs 0.000 claims abstract description 3
- 230000008439 repair process Effects 0.000 claims abstract description 3
- 229940074410 trehalose Drugs 0.000 claims abstract description 3
- 230000000694 effects Effects 0.000 claims description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 30
- 238000005303 weighing Methods 0.000 claims description 16
- 238000010438 heat treatment Methods 0.000 claims description 14
- 239000000284 extract Substances 0.000 claims description 13
- 239000008367 deionised water Substances 0.000 claims description 12
- 229910021641 deionized water Inorganic materials 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 8
- 239000004480 active ingredient Substances 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 230000036571 hydration Effects 0.000 claims description 7
- 238000006703 hydration reaction Methods 0.000 claims description 7
- 239000011159 matrix material Substances 0.000 claims description 7
- 230000003647 oxidation Effects 0.000 claims description 7
- 238000007254 oxidation reaction Methods 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 238000002791 soaking Methods 0.000 claims description 5
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 4
- 244000042664 Matricaria chamomilla Species 0.000 claims description 4
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 4
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims description 4
- 238000004108 freeze drying Methods 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- 241000628997 Flos Species 0.000 claims description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 3
- 238000007710 freezing Methods 0.000 claims description 3
- 230000008014 freezing Effects 0.000 claims description 3
- 235000008434 ginseng Nutrition 0.000 claims description 3
- 229920000136 polysorbate Polymers 0.000 claims description 3
- 229950008882 polysorbate Drugs 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 239000008213 purified water Substances 0.000 claims description 3
- 238000003892 spreading Methods 0.000 claims description 3
- 230000007480 spreading Effects 0.000 claims description 3
- 238000010025 steaming Methods 0.000 claims description 3
- 239000000686 essence Substances 0.000 claims description 2
- 244000131316 Panax pseudoginseng Species 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- 210000004027 cell Anatomy 0.000 abstract description 36
- 235000016709 nutrition Nutrition 0.000 abstract description 4
- 230000035764 nutrition Effects 0.000 abstract description 4
- 150000004670 unsaturated fatty acids Chemical class 0.000 abstract description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 abstract description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 abstract description 2
- 239000002516 radical scavenger Substances 0.000 abstract description 2
- 229910052711 selenium Inorganic materials 0.000 abstract description 2
- 239000011669 selenium Substances 0.000 abstract description 2
- 229940123457 Free radical scavenger Drugs 0.000 abstract 1
- 244000061176 Nicotiana tabacum Species 0.000 abstract 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 210000002569 neuron Anatomy 0.000 abstract 1
- 210000004273 ophthalmic nerve Anatomy 0.000 abstract 1
- 235000013772 propylene glycol Nutrition 0.000 abstract 1
- 239000003921 oil Substances 0.000 description 90
- 235000019198 oils Nutrition 0.000 description 88
- 210000003491 skin Anatomy 0.000 description 53
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 28
- 239000000243 solution Substances 0.000 description 28
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 14
- 229930003268 Vitamin C Natural products 0.000 description 14
- 235000019154 vitamin C Nutrition 0.000 description 14
- 239000011718 vitamin C Substances 0.000 description 14
- 239000012528 membrane Substances 0.000 description 13
- 239000002158 endotoxin Substances 0.000 description 12
- 229920006008 lipopolysaccharide Polymers 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 9
- 238000002835 absorbance Methods 0.000 description 9
- 235000019441 ethanol Nutrition 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 102000003425 Tyrosinase Human genes 0.000 description 8
- 108060008724 Tyrosinase Proteins 0.000 description 8
- 210000001328 optic nerve Anatomy 0.000 description 8
- 238000004090 dissolution Methods 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 230000001681 protective effect Effects 0.000 description 6
- 230000006641 stabilisation Effects 0.000 description 6
- 238000011105 stabilization Methods 0.000 description 6
- 230000000638 stimulation Effects 0.000 description 6
- 238000009210 therapy by ultrasound Methods 0.000 description 6
- 230000037303 wrinkles Effects 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 208000003464 asthenopia Diseases 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 5
- 239000010491 poppyseed oil Substances 0.000 description 5
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 5
- 238000002390 rotary evaporation Methods 0.000 description 5
- 206010020751 Hypersensitivity Diseases 0.000 description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 208000026935 allergic disease Diseases 0.000 description 4
- 230000007815 allergy Effects 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000007865 diluting Methods 0.000 description 4
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 4
- 240000005979 Hordeum vulgare Species 0.000 description 3
- 235000007340 Hordeum vulgare Nutrition 0.000 description 3
- 230000002292 Radical scavenging effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- 239000008055 phosphate buffer solution Substances 0.000 description 3
- 150000003904 phospholipids Chemical class 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 241000208340 Araliaceae Species 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000000887 face Anatomy 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- AKPUJVVHYUHGKY-UHFFFAOYSA-N hydron;propan-2-ol;chloride Chemical compound Cl.CC(C)O AKPUJVVHYUHGKY-UHFFFAOYSA-N 0.000 description 2
- 239000003547 immunosorbent Substances 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 208000020154 Acnes Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 206010052139 Eye oedema Diseases 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 235000008753 Papaver somniferum Nutrition 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 241000167686 Reichardia Species 0.000 description 1
- 241000195474 Sargassum Species 0.000 description 1
- 102000019259 Succinate Dehydrogenase Human genes 0.000 description 1
- 108010012901 Succinate Dehydrogenase Proteins 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 235000005811 Viola adunca Nutrition 0.000 description 1
- 240000009038 Viola odorata Species 0.000 description 1
- 235000013487 Viola odorata Nutrition 0.000 description 1
- 235000002254 Viola papilionacea Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241000589636 Xanthomonas campestris Species 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 230000002900 effect on cell Effects 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000000887 hydrating effect Effects 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 239000002539 nanocarrier Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000012599 radical scavenging assay Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000010117 shenhua Substances 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000037317 transdermal delivery Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明公开了一种具有美白抗氧化和修复功能的御米油脂质体的制备方法和应用。该御米油脂质体可应用于化妆品中,制备眼霜、眼贴、精华、乳液、面膜等多种产品剂型,主要成分包括:御米油,卵磷脂,DSPE‑PEG2000,茶多酚,烟酰胺,透明质酸,洋甘菊提取物,人参皂苷,海藻糖,维生素E,丙二醇,甘油,海藻酸钠,黄原胶,聚山梨酯80,苯氧乙醇,脱氢乙酸钠和水。御米油中硒和不饱和脂肪酸含量丰富,具有极强的抗氧化作用,是自由基的清除剂,研究发现可使得氧化受损的眼神经细胞得到很好的修复。本发明通过添加御米油,配合洋甘菊提取物和人参皂苷制备了一种美白抗氧化的御米油脂质体,其同时具有很强的眼神经细胞营养修复功能。
Description
技术领域
本发明涉及化妆品技术领域,尤其涉及一种具有美白抗氧化和修复功能的御米油脂质体及其在化妆品中的应用。
背景技术:
御米油,又叫罂粟籽油,是从灭活的罂粟籽经过水提、醇提、萃取、浓缩和干燥等工艺获取的一种不含吗啡、安全的新型食用植物油,含有100多种对人体有益的维生素、微量元素及丰富的多糖、多肽、醇类、黄酮等天然活性物质,尤其是富含人体10多种人体必需却不能自身合成的不饱和脂肪酸,其中包含7种脂肪酸,主要以亚油酸为主。
御米油中富含硒元素,具有极强的抗氧化作用,是自由基的清除剂,能解除有害金属物质的毒性,减少化妆品中铅的毒性,保护皮肤、增白美容。御米油的不饱和脂肪酸含量87.7%以上,天然维生素E的含量达68.2mg/100g,能清理人体内的氧自由基,阻止生理色斑的产生,对紫外线灼伤的皮肤起良好的修护作用;御米油含有丰富的多肽成份,可淡化色斑,舒展皱纹,改善面部微循环,使皮肤明润光泽;补充氨基酸,促进新陈代谢,排毒养颜。通过御米油日常护理,可以舒缓眼角皱纹,使女性拥有一双明眸善睐的眼睛。御米油中丰富的糖、醇类及多肽物质可抑制过氧化脂质,增加细胞活性,提高免疫力、抗辐射。提高神经反射敏感性,增加耐力、抗疲劳,提高细胞免疫的功能。
洋甘菊自古以来在欧洲就有“神花”之称,其所拥有的美容价值和药用价值是十分强大的,洋甘菊富含黄酮类活性成分,该成分具有抗氧化、抗血管增生、消炎、抗变应性,通过现代技术可对洋甘菊活性成分进行提取并应用于眼霜产品制作之中。具有舒缓淤血的功效,可以缓解疲劳和眼部浮肿,改善过敏,哪怕是过敏肌肤也可以放心使用。
洋甘菊提取物有良好的护肤作用,能够很好地舒缓皮肤,防护辐射损伤,抵抗肌肤敏感,增强皮肤防护屏障,调节肌肤的水油平衡,加速痘痘的愈合,还能延缓肌肤衰老。洋甘菊提取物还具有广泛的药理作用,可以抗菌、抗病毒、抗过敏。其中富含的黄酮类化合物,使其还可以抗氧化抗炎症。因此洋甘菊提取物经常被加入面膜中,能够给肌肤深层补水,快速舒缓肌肤敏感,缓解红敏、瘙痒、晒伤等肌肤问题。
人参皂苷是人参提取物中主要的活性成分,具有强效减除肌肤黑色素,淡化及阻止黑色素的形成的功效。加在护肤品中可以显著增加肌肤锁水能力,软化皮肤角质化细胞,促进皮下毛细血管的血液循环,增加皮肤的营养供应,防止动脉硬化,调节皮肤水分平衡。所以它能延缓皮肤衰老,防止皮肤干燥脱水,增加皮肤的弹性,从而起到保护皮肤光泽柔嫩,防止和减少皮肤皱纹的作用。
茶多酚具有很好地抗氧化性、抗衰老、抑菌、清除自由基、改善异味等性能。它被认为是绿色环保的天然成品,在化妆品领域应用广泛。
海藻酸钠是从褐藻类的海带或马尾藻中提取碘和甘露醇之后的副产物,是一种天然多糖,具有稳定性、溶解性、粘性和安全性。海藻酸钠用于化妆品中能增加肌肤的保水性、紧缩性及弹性,使松弛的肌肤回复年轻状态,并可因此达到祛除皱纹的目的。
黄原胶是由甘蓝黑腐病黄单胞菌发酵产生的一种大分子细胞外杂多糖,在水溶液中形成刚性的双螺旋构象,稳定性高。黄原胶溶液是典型的假塑性流体,其粘度随剪切速率的增加而急剧下降。在高剪切速率时,黄原胶溶液粘度较低,使其很容易被混合;在低剪切速率时,溶液具有高粘度,具有良好的增稠性,可作为增稠剂应用于化妆品中。
海藻糖是一种天然的糖类,有较好的配伍性、相容性和稳定性,几乎可以添加到任何化妆品中。它能够抑制化妆品中脂肪酸及酯类的氧化酸败,保持各种蛋白质及多肽类活性成分的功效,还具有优异的保水性和吸湿性,透明质酸与海藻糖联合应用,互补增效,兼具生物保鲜和智能保湿作用,可以始终保持组织和皮肤及化妆品本身的“新鲜”。
现有眼霜产品中活性成分仅停留于皮肤角质层,难以进入基底层细胞,发挥抗氧化抗皱、去黑眼圈、去脂肪粒、改善皮肤状态的根本作用,大多只能在角质层起到保湿润肤的效果。活性成分因为缺乏好的皮肤深层递送系统而大多被浪费,不能达到理想效果。
脂质体是以磷脂为主要材料构成的双分子层囊泡,最早由英国科学家发现,其结构类似生物膜。上世纪70年代脂质体开始成为药物载体,由于其生物相容性、生物可降解性、无毒和无免疫原性优点,脂质体作为药物新剂型迅速发展,目前已有十余种脂质体制剂上市。在透皮作用研究中,有研究表明粒径为20-200nm的脂质体能作为局部用药的活性载体,借助细胞间隙途径渗透进入活体表皮。脂质体在化妆品中的优点除了透皮以外,还有保护光、热、氧化不稳定的有效成分保持活性和稳定的作用。
通过检索,发现如下已公开专利文献:御米油大麦青汁粉(CN110506934A),御米油和大麦青汁粉的配比为1:20,御米油和大麦青汁粉按比例加水混合后干燥成粉末状,方便人们合理定量地食用,更好地吸收;另有公开专利(CN 1520802A)以灭活罂粟籽油制备了用于缓解皮肤表面瘙痒的油蜜、润肤油等,只针对皮肤表面,不涉及皮肤渗透递送;另有公开专利(CN 106389234B)利用水相和油相混合制备乳剂的方式包载四种抗衰成分,其中包括御米油,乳剂与脂质体制剂显著不同,不具备双层膜结构,难以实现皮肤深层递送;另有公开专利(CN 108310120A)涉及一种包含15种中药的用于缓解眼睛疲劳的中药处方,但并没有对上述处方的功效进行评价,也没有相关缓解视疲劳的依据;另有公开专利(CN101028071A)涉及罂粟籽油提取物的制备和应用,该提取物是以罂粟籽油为原料加工提取而来,与罂粟籽油自身不同。综上所述,本发明专利申请与以上公开专利存在本质不同。
目前现有专利绝大多数将御米油作为植物油应用在食品中,御米油在化妆品中的应用潜力亟待发掘。首先,本发明利用脂质体纳米技术将御米油包载于纳米载体的磷脂双分子层间,一方面解决御米油水溶性差难以分散的问题,显著提高御米油在化妆品中的溶解分散状态,方便与其他组分充分混合,另一方面显著提高御米油的透皮递送能力,透过角质层直达基底层,并能够与其他提取物共同包载实现协同效应。接着,通过处方筛选配比,我们发现本发明中的御米油复方脂质体不仅具有美白、抗氧化功效,更具有对于视神经细胞的应激损伤保护作用。
发明内容
本发明的目的是克服现有技术中的御米油水溶性差难分散、透皮效果差难以递送进入皮肤基底层等不足,提供一种具有美白抗氧化和修复功能的御米油脂质体及其制备方法,提高御米油水中分散度和稳定性的同时,使其通过脂质体技术递送到眼部周围的皮肤基底层,甚至真皮层,从而增强美白抗氧化效果,提亮眼周、抚平细纹,并营养修复视神经细胞,缓解视疲劳。
本发明解决其技术问题所采用的技术方案是:
一种具有美白抗氧化和修复功能的御米油脂质体,其重量组成成分的含量为:御米油3-10份,卵磷脂10-30份,DSPE-PEG20001-5份,洋甘菊提取物1-5份,人参皂苷提取物1-5份,去离子水补足至100份。
所述御米油脂质体的制备方法为:按一定质量比例称取卵磷脂和DSPE-PEG2000,加入御米油,再加入适量的无水乙醇,振荡溶解,水浴加热旋蒸铺膜,再加洋甘菊提取物和人参皂苷提取物溶液进行水化,超声过膜得御米油脂质体。
所述人参皂苷的制备方法如下:取人参,粉碎,加入10倍体积的纯净水,80-100℃加热回流2h,冷却后真空抽滤得滤液,经-20℃、-80℃预冻后放入冷冻干燥机,以-80℃冻干,12h后得人参皂苷干粉。
所述洋甘菊提取物的制备方法如下:称取洋甘菊的茎和叶,粉碎,加入水,茎和叶:水的体积比为1:1-1:5,浸泡4-8小时,80-120℃回流提取6-10小时,过滤,收集水层,水层冻干,即得洋甘菊提取物。
添加有这种具有美白抗氧化和修复功能的御米油脂质体的眼霜制剂,其重量组成成分的含量为:御米油脂质体10-30份,茶多酚1份,烟酰胺0.1-0.3份,透明质酸0.1-0.5份,海藻糖1-5份,维生素E 5-10份,丙二醇10-30份,甘油1-5份,海藻酸钠0.1-0.3份,黄原胶0.3-0.7份,聚山梨酯801-3份,苯氧乙醇0.1-0.5份,脱氢乙酸钠0.1-0.5份,去离子水补足至100份。
上述御米油脂质体眼霜的制备方法,步骤如下:
S1,按比例将聚山梨酯80溶于水中,加热使混合均匀;
S2,按比例将黄原胶,海藻酸钠加入上述溶液中,搅拌使成混合均匀的凝胶基质,在50-80℃条件下将包载活性成分的御米油脂质体加入凝胶基质,搅拌至均匀后再加入维生素E,继续搅拌至均匀,保温10min;
S3,待温度降至35℃,按比例将透明质酸、苯氧乙醇、脱氢乙酸钠、烟酰胺、海藻糖、甘油、丙二醇、茶多酚,加入去离子水中制得的水溶液加入其中,搅拌至均匀,即得。本发明取得的优点和积极效果为:
1.本发明首次将御米油运用到眼霜、眼贴、精华液等眼周护肤品设计中,将御米油与洋甘菊提取物,人参皂苷利用脂质体技术一起混合包载,合理科学地设计了多种组分及配比,优化筛选脂质体纳米技术工艺参数,将御米油的护肤效果发挥到极致,并首次发现御米油的营养视神经作用。
2、本发明通过将御米油包载于脂质体磷脂双分子层间,实现御米油在水相基质中的均匀分散。
3、要实现透过皮肤角质层递送进入基底层细胞的目标,药物制剂必须同时具备亲脂性和亲水性。御米油本身仅具有亲脂性,完全不具备亲水性,大多滞留于皮肤表面,难以进入基底层发挥护肤效果,将其包载于脂质体后,透皮性显著强,可深层递送至皮肤基底层,对于皮肤薄嫩的眼周皮肤来说,甚至可递送至真皮层,能够同时起到美白抗氧化的作用,还可以营养眼部神经,缓解视疲劳。
附图说明
图1为本发明中御米油脂质体三次测量的粒径分布图,每条曲线为测量一次的结果;
图2为本发明中御米油脂质体三次测量的Zeta电势分布图,每条曲线为测量一次的结果;
图3为本发明中不同浓度的御米油脂质体对酪氨酸酶活性抑制率图;
图4为本发明中御米油脂质体保护后视神经细胞BV2在脂多糖刺激下的效果图;
图5为本发明中御米油脂质体保护后视神经细胞BV2在双氧水刺激下的效果图;
图6为本发明中脂多糖刺激后的视神经细胞BV2图;
图7为本发明中添加御米油脂质体保护后用脂多糖刺激后的视神经细胞BV2图。
具体实施方式
下面详细叙述本发明的实施例,需要说明的是,本实施例是叙述性的,不是限定性的,不能以此限定本发明的保护范围。
本发明中所使用的原料,如无特殊说明,均为常规的市售产品;本发明中所使用的方法,如无特殊说明,均为本领域的常规方法。
除非另有定义,本发明所使用的所有的技术和科学术语与属于本发明的技术领域的技术人员通常理解的含义相同。本发明中在本发明的说明书中所使用的术语只是为了描述具体的实施例的目的,不是旨在于限制本发明。本发明所使用的术语“和/或”包括一个或多个相关的所列项目的任意的和所有的组合。
下面结合实施例,进一步阐述本发明:
对比例1维生素C水溶液
准确称取10mg维生素C,至于10ml容量瓶中,加少量水溶解后,稀释定容,摇匀,得到1mg/ml的维生素C水溶液,梯度稀释至0.8mg/ml,0.6mg/ml,0.4mg/ml,0.2mg/ml。
对比例2维生素C乙醇溶液
准确称取10mg纯维生素C,至于10ml容量瓶中,加少量乙醇溶解后,稀释定容,摇匀,得到1mg/ml的维生素C乙醇溶液,梯度稀释至0.8mg/ml,0.6mg/ml,0.4mg/ml,0.2mg/ml。
实施例1御米油乙醇溶液
准确量取御米油250mg,溶于5ml乙醇,得到50mg/ml的御米油乙醇溶液,梯度稀释至40mg/ml,30mg/ml,20mg/ml,10mg/ml。
实施例2空白脂质体的制备
称取卵磷脂20g和DSPE-PEG20005g,再加入适量的无水乙醇,振荡溶解,水浴加热旋蒸铺膜,再加去离子水进行水化75g,5%功率下超声2min,过0.22μm滤膜整粒除菌,得空白脂质体。
实施例3御米油脂质体的制备:
首先称取卵磷脂10g,御米油1g,再加入适量的无水乙醇,振荡溶解,水浴加热旋蒸铺膜,再加去离子水进行水化89g,5%功率下超声2min,过0.22μm滤膜整粒除菌,得实施例3。
实施例4御米油脂质体的制备:
首先称取卵磷脂30g,御米油1g,再加入适量的无水乙醇,振荡溶解,水浴加热旋蒸铺膜,再加去离子水进行水化69g,5%功率下超声2min,过0.22μm滤膜整粒除菌,得实施例4。
实施例5御米油脂质体的制备:
首先称取卵磷脂30g,御米油1g,再加入适量的无水乙醇,振荡溶解,水浴加热旋蒸铺膜,再加去离子水进行水化69g,5%功率下超声8min,过0.22μm滤膜整粒除菌,得实施例5。
实施例6御米油脂质体的制备:
首先称取卵磷脂18g,御米油1g,再加入适量的无水乙醇,振荡溶解,水浴加热旋蒸铺膜,再加去离子水进行水化81g,5%功率下超声10min,过0.22μm滤膜整粒除菌,得实施例6。
实施例7御米油脂质体的制备
称取卵磷脂20g和DSPE-PEG20005g,加入御米油5g,再加入适量的无水乙醇,振荡溶解,水浴加热旋蒸铺膜,再加洋甘菊提取物和人参皂苷提取物溶液70g(其中溶解有洋甘菊提取物2g,人参皂苷2g),进行水化,5%功率下超声2min,过0.22μm滤膜整粒除菌,得实施例7,其粒径电位测量见附图1和附图2。
所述人参皂苷的制备方法如下:取人参,粉碎,加入10倍体积的纯净水,80℃加热回流2h,冷却后真空抽滤得滤液,经-20℃、-80℃预冻后放入冷冻干燥机,以-80℃冻干,12h后得人参皂苷干粉。
所述洋甘菊提取物的制备方法如下:称取洋甘菊的茎和叶,粉碎,加入水,茎和叶:水的体积比为1:4,浸泡8小时,80℃回流提取6小时,过滤,收集水层,水层冻干,即得洋甘菊提取物。
实施例8御米油脂质体眼霜的制备
取聚山梨酯802g溶于25g水中,加热使混合均匀;
取黄原胶0.5g,海藻酸钠0.2g,加入上述溶液中,搅拌使成混合均匀的凝胶基质,在60℃条件下将包载活性成分的御米油脂质体25g加入凝胶基质,搅拌至均匀后再加入维生素E 5g,继续搅拌至均匀,保温10min;
待温度降至35℃,按比例将透明质酸0.5g、苯氧乙醇0.2g、脱氢乙酸钠0.3g、烟酰胺0.3g,海藻糖5g,甘油2g,丙二醇10g,茶多酚1g,去离子水补足至100g,搅拌至均匀,即得。
试验例1御米油脂质体包载能力评价
将配制的不同包载比例的御米油脂质体室温下放置,观察放置10天,20天,30天,60天后御米油脂质体的状态。
实验结果
表1
时间/状态 | 第1天 | 第10天 | 第20天 | 第30天 | 第60天 |
实施例2 | 佳 | 佳 | 佳 | 佳 | 佳 |
实施例3 | 佳 | 佳 | 不佳 | 不佳 | 不佳 |
实施例4 | 佳 | 佳 | 不佳 | 不佳 | 不佳 |
实施例5 | 佳 | 佳 | 佳 | 不佳 | 不佳 |
实施例6 | 佳 | 佳 | 不佳 | 不佳 | 不佳 |
实施例7 | 佳 | 佳 | 佳 | 佳 | 佳 |
通过观察室温下放置不同时间后的御米油脂质体状态,发现实施例2和实施例7中的脂质体状态最佳,说明卵磷脂与DSPE-PEG2000组合使用可提高脂质体的稳定性,故最终选用实施例7制备的御米油脂质体进行接下来的实验评价。
试验例2美白效果评价
溶液配制:以常规配制方法制备pH 6.8的磷酸盐缓冲液50ml;称取适量酪氨酸加水溶解,制备2mmol/L的酪氨酸溶液,及浓度为500U/ml的酪氨酸酶溶液。
酪氨酸酶活力测定
取96孔板,每孔加入pH 6.8的磷酸盐缓冲液100μl,上述酪氨酸溶液50μl,将实施例7和对比例1进行系列浓度稀释后,同浓度实验孔(n=3)分别加入10μl,进行比较。待混合均匀后,在冰浴中迅速加入酪氨酸酶溶液10μl,混匀,37℃孵育10min,于475nm处测定吸光度。
酪氨酸酶抑制率(%)=[(A-B)-(C-D)]/[A-B]×100%
A:未加御米油脂质体的加酶混合液所测的吸光度;
B:未加御米油脂质体亦未加酶的混合液所测的吸光度;
C:加御米油脂质体和酶的混合液所测的吸光度;
D:加御米油脂质体而未加酶的混合液所测的吸光度。
以上每个实验孔有3个复孔,即n=3。
表2酪氨酸酶抑制率测定实验结果(n=3)
综合附图3御米油脂质体对酪氨酸酶活性抑制率图,从表格数据得知,在0.2-1mg/ml浓度范围内,御米油脂质体对酪氨酸酶的活性抑制具有浓度依赖性,并且与维生素C美白效果相差不大。
试验例3:抗氧化效果评价
溶液配制:称取4mg DPPH自由基粉末至100ml容量瓶中,用无水乙醇溶解,稀释定容,摇匀,得0.04mg/mL的DPPH溶液。
清除DPPH自由基实验:取96孔板,滴加100μl DPPH溶液,再分别加入100μl对比例2或100μl实施例1,混合均匀,室温条件下避光反应20min,515nm测定紫外吸光度(B)。
对照组:0.2-1mg/ml的对比例2;实验组:10-50mg/ml的实施例1。
DPPH自由基清除率(%)=(1-B/A)×100%
其中,A:空白吸光度;B:样品吸光度。
以上实验设置平行实验孔3个,即n=3。
表3维生素C DPPH自由基清除率测定实验结果(n=3)
对比例2/清除率(%) | 实验孔1 | 实验孔2 | 实验孔3 | 平均值±SD |
0.2mg/ml | 46.689 | 48.667 | 47.763 | 47.706±0.990 |
0.4mg/ml | 51.490 | 51.333 | 52.632 | 51.818±0.709 |
0.6mg/ml | 53.477 | 53.667 | 53.289 | 53.478±0.189 |
0.8mg/ml | 56.457 | 55.833 | 57.566 | 56.619±0.877 |
1mg/ml | 60.099 | 60.667 | 59.539 | 60.102±0.564 |
表4御米油DPPH自由基清除率测定实验结果(n=3)
实施例1/清除率(%) | 实验孔1 | 实验孔2 | 实验孔3 | 平均值±SD |
0.2mg/ml | 10.089 | 9.524 | 8.783 | 9.465±0.655 |
0.4mg/ml | 15.395 | 13.844 | 14.286 | 14.508±0.799 |
0.6mg/ml | 22.342 | 21.769 | 20.908 | 21.673±0.722 |
0.8mg/ml | 32.237 | 34.194 | 32.653 | 33.028±1.031 |
1mg/ml | 38.816 | 40.497 | 39.694 | 39.669±0.841 |
从表格数据可知,御米油具有剂量依赖性抗氧化活性,维生素C活性过高,在储存过程中难以维持抗氧化能力,经常逐步损失,影响货架期。与维生素C相比,御米油抗氧化能力比较稳定,持久,更适宜添加进入护肤品中。
试验例4明目效果评价
以脂多糖,双氧水刺激离体培养的小鼠视神经BV2细胞,通过MTT法检测细胞的存活率,来表征实施例对视神经细胞的保护效果。
MTT法:检测原理为活细胞线粒体中的琥珀酸脱氢酶能使外源性MTT还原为水不溶性的蓝紫色结晶甲臜(Formazan)并沉积在细胞中,而死细胞无此功能。二甲基亚砜(DMSO)能溶解细胞中的甲臜,用酶联免疫检测仪在492nm、630nm波长处测定其光吸收值,可间接反映活细胞数量。在一定细胞数范围内,MTT结晶形成的量与细胞数成正比。因BV2为半贴壁细胞,与一般贴壁细胞的MTT测定方法不同,采取以下方法进行:
取96孔板,每孔加90μl细胞悬液,细胞密度为5×104个/mL,37℃,5%CO2孵育24h;每孔加实施例710μl(1:10)预保护(n=6),1h后加终浓度为100μmol/L的双氧水溶液10μl;2h后加每孔20μl MTT溶液,继续培养4h;终止培养,加入盐酸异丙醇100μl溶解甲瓒,孵育10min;在酶联免疫检测仪上492nm、630nm波长处测得各孔的光密度值(OD值);
细胞存活率={(OD值-空白组OD值[均值])/(DMSO组OD值-空白组OD}×100%
实验结果:御米油脂质体对于100μmol/L双氧水刺激BV2细胞的保护作用评价
表5御米油脂质体对于双氧水刺激BV2细胞的保护作用结果
从数据中可以看出,在御米油脂质体浓度为0.20mg/mL时,细胞存活率最高,与H2O2组对比,加药后对细胞具有一定的保护效果,见附图4。
取96孔板,每孔加90μl细胞悬液,细胞密度为5×104个/mL,37℃,5%CO2孵育24h;每孔加实施例710μl(1:10)预保护(n=6),1h后加终浓度为1μg/mL的脂多糖(LPS)溶液0.5μl;2h后加每孔20μl MTT溶液,继续培养4h;终止培养,加入盐酸异丙醇100μl溶解甲瓒,孵育10min;在酶联免疫检测仪上492nm、630nm波长处测得各孔的光密度值(OD值);
细胞存活率={(OD值-空白组OD值[均值])/(DMSO组OD值-空白组OD}×100%
实验结果:御米油脂质体对于1μg/mL脂多糖刺激BV2细胞的保护作用评价
表6御米油脂质体对于脂多糖刺激BV2细胞的保护作用结果
从数据中可以看出,在御米油脂质体浓度为0.08mg/mL时,细胞存活率均值最高(166.6%),与LPS组对比,加药后也可以有效保护细胞并且促进细胞增殖,见附图5。此浓度下对细胞也不产生毒性,为最适宜御米油脂质体浓度。单纯LPS刺激的BV2细胞状态见附图6,加实施例7保护后再加LPS的细胞状态见附图7,可见实施例7的添加对于LPS对细胞的损伤具有明显保护作用。
试验例5体外透皮吸收评价
1.离体皮肤制备:将老鼠处死剥离其腹部皮肤,去除皮下脂肪进行脱毛处理,配制一定量的硫化氢溶液将其鼠皮浸泡数分钟后,用镊子取出,小刀刮去皮肤上已经褪去的鼠毛。用生理盐水洗净,以滤纸吸干水分,再用磷酸盐缓冲液漂洗至洗液澄清,用滤纸吸干后,福尔马林4℃浸泡保存,备用。
2.透皮吸收试验:采用TK-6H1型透皮扩散试验仪,将上述处理好的鼠皮固定在扩散池的供给池与接受池之间,真皮层面向左,角质层面向右,排尽气泡。在右侧供给池中加入3ml含空白脂质体,2ml生理盐水。接受池内加入5ml生理盐水,以300r/min的速度搅拌混匀,设定温度为(33±0.1)℃。分别于1、2、3、4、5、6h从左侧接受池中取出200μl介质,同时向接受池中补加等量的接收液(生理盐水)。
吸出接收液,采用考马斯亮蓝法进行含量的测定。
取上述接受液20μl加入100μl考马斯亮蓝染液于96孔板中,于595nm酶标仪测其吸光度。
表7空白脂质体透皮评价结果
从表格数据得知,空白脂质体的透皮率高,且随时间延长呈增长趋势,所以我们选用包载御米油的脂质体制备眼霜及系列化妆品。
试验例6产品感官及效果测试
以实施例8为实验组,市售两款普通眼霜作为对照组。选择志愿者(25-55岁)男性、女性各9人(共18人),随机平均分为3组(每组6人),每天清洁皮肤后将实验组和对照组涂于面部,30天后观察效果。根据皮肤状态变化分别对不同项目进行打分(0-100分),结果如下表8所示。
表8产品使用感官评分结果
实施例8 | 对照组一 | 对照组二 | |
渗透性 | 97.2±2.5 | 84.4±5.2 | 86.4±3.2 |
保湿性 | 98.1±3.7 | 86.2±4.1 | 85.1±1.2 |
清爽性 | 94.0±1.1 | 82.5±3.3 | 88.8±1.4 |
皱纹变化 | 93.5±2.4 | 83.8±6.2 | 87.5±2.5 |
消除黑眼圈 | 95.6±5.1 | 63.9±1.4 | 84.2±4.6 |
缓解视疲劳 | 95.7±1.2 | 无明显效果 | 无明显效果 |
综上以上结果发现,本发明制得的御米油脂质体纳米眼霜(实施例8)各项效果最优,特别具有其他眼霜产品不具有的缓解视疲劳功能。
尽管为说明目的公开了本发明的实施例,但是本领域的技术人员可以理解:在不脱离本发明及所附权利要求的精神和范围内,各种替换、变化和修改都是可能的,因此,本发明的范围不局限于实施例和附图所公开的内容。
Claims (10)
1.一种具有美白抗氧化和修复功能的御米油脂质体,其特征在于:该重量组成成分的含量为:御米油3-10份,卵磷脂10-30份,DSPE-PEG20001-5份,洋甘菊提取物1-5份,人参皂苷提取物1-5份,去离子水补足至100份。
2.如权利要求1所述的一种具有美白抗氧化和修复功能的御米油脂质体,其特征在于:所述御米油脂质体的制备方法为:按一定质量比例称取卵磷脂和DSPE-PEG2000,加入御米油,再加入适量的无水乙醇,振荡溶解,水浴加热旋蒸铺膜,再加洋甘菊提取物和人参皂苷提取物溶液进行水化,超声过膜得御米油脂质体。
3.如权利要求1所述的一种具有美白抗氧化和修复功能的御米油脂质体,其特征在于:所述人参皂苷的制备方法如下:取人参,粉碎,加入10倍体积的纯净水,80-100℃加热回流2h,冷却后真空抽滤得滤液,经-20℃、-80℃预冻后放入冷冻干燥机,以-80℃冻干,12h后得人参皂苷干粉。
4.如权利要求1所述的一种具有美白抗氧化和修复功能的御米油脂质体,其特征在于:所述洋甘菊提取物的制备方法如下:称取洋甘菊的茎和叶,粉碎,加入水,茎和叶:水的体积比为1:1-1:5,浸泡4-8小时,80-120℃回流提取6-10小时,过滤,收集水层,水层冻干,即得洋甘菊提取物。
5.一种添加有如权利要求1所述的一种具有美白抗氧化和修复功能的御米油脂质体的眼霜制剂,其特征在于:该重量组成成分的含量为:御米油脂质体10-30份,茶多酚1份,烟酰胺0.1-0.3份,透明质酸0.1-0.5份,海藻糖1-5份,维生素E 5-10份,丙二醇10-30份,甘油1-5份,海藻酸钠0.1-0.3份,黄原胶0.3-0.7份,聚山梨酯801-3份,苯氧乙醇0.1-0.5份,脱氢乙酸钠0.1-0.5份,去离子水补足至100份。
6.一种如权利要求5所述的御米油脂质体眼霜的制备方法,其特征在于:步骤如下:
S1,按比例将聚山梨酯80溶于水中,加热使混合均匀;
S2,按比例将黄原胶,海藻酸钠加入上述溶液中,搅拌使成混合均匀的凝胶基质,在50-80℃条件下将包载活性成分的御米油脂质体加入凝胶基质,搅拌至均匀后再加入维生素E,继续搅拌至均匀,保温10min;
S3,待温度降至35℃,按比例将透明质酸、苯氧乙醇、脱氢乙酸钠、烟酰胺、海藻糖、甘油、丙二醇、茶多酚,加入去离子水中制得的水溶液加入其中,搅拌至均匀,即得。
7.一种如权利要求5所述的御米油脂质体眼霜,其特征在于:所用的防腐剂为苯氧乙醇与脱氢乙酸钠。
8.一种如权利要求5所述的御米油脂质体眼霜,其特征在于:将透明质酸与海藻糖联合应用,互补增效,兼具生物保鲜和智能保湿作用。
9.一种如权利要求5所述的御米油脂质体眼霜,其特征在于:将海藻糖与茶多酚联合使用,提高茶多酚的稳定性。
10.如权利要求1所述的一种美白抗氧化的御米油脂质体在化妆品中的应用,如眼霜、眼贴、精华液、面霜、乳液、面膜等。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110647996.5A CN113413332A (zh) | 2021-06-10 | 2021-06-10 | 一种具有美白抗氧化和修复功能的御米油脂质体 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110647996.5A CN113413332A (zh) | 2021-06-10 | 2021-06-10 | 一种具有美白抗氧化和修复功能的御米油脂质体 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113413332A true CN113413332A (zh) | 2021-09-21 |
Family
ID=77788300
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110647996.5A Pending CN113413332A (zh) | 2021-06-10 | 2021-06-10 | 一种具有美白抗氧化和修复功能的御米油脂质体 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113413332A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114533597A (zh) * | 2022-01-07 | 2022-05-27 | 北京理工大学重庆创新中心 | 一种美白抗老抗病毒的超分子脂质体精华液及其制备方法 |
CN116407459A (zh) * | 2023-05-15 | 2023-07-11 | 广州新妆生物科技有限公司 | 一种具有美白养颜抗辐射功能的精华及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101028071A (zh) * | 2007-04-16 | 2007-09-05 | 周文志 | 罂粟籽油提取物及其制备方法和用途 |
CN102366395A (zh) * | 2011-09-27 | 2012-03-07 | 沈志荣 | 一种包含皮肤调理剂和水溶性硅蜡的化妆水组合物及其制备方法 |
CN103479557A (zh) * | 2013-10-07 | 2014-01-01 | 上海方木精细化工有限公司 | 洋甘菊抗菌湿巾及其制备方法 |
CN104784099A (zh) * | 2015-04-01 | 2015-07-22 | 广西大学 | 一种抗敏美白面膜粉 |
CN111417380A (zh) * | 2017-10-27 | 2020-07-14 | 嘉吉公司 | 个人护理产品 |
-
2021
- 2021-06-10 CN CN202110647996.5A patent/CN113413332A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101028071A (zh) * | 2007-04-16 | 2007-09-05 | 周文志 | 罂粟籽油提取物及其制备方法和用途 |
CN102366395A (zh) * | 2011-09-27 | 2012-03-07 | 沈志荣 | 一种包含皮肤调理剂和水溶性硅蜡的化妆水组合物及其制备方法 |
CN103479557A (zh) * | 2013-10-07 | 2014-01-01 | 上海方木精细化工有限公司 | 洋甘菊抗菌湿巾及其制备方法 |
CN104784099A (zh) * | 2015-04-01 | 2015-07-22 | 广西大学 | 一种抗敏美白面膜粉 |
CN111417380A (zh) * | 2017-10-27 | 2020-07-14 | 嘉吉公司 | 个人护理产品 |
Non-Patent Citations (2)
Title |
---|
刘波: "功能养生油研制成功", 《航空港》 * |
康建之: "神奇的御米油", 《中国医药指南》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114533597A (zh) * | 2022-01-07 | 2022-05-27 | 北京理工大学重庆创新中心 | 一种美白抗老抗病毒的超分子脂质体精华液及其制备方法 |
CN114533597B (zh) * | 2022-01-07 | 2024-01-12 | 北京理工大学重庆创新中心 | 一种美白抗老抗病毒的超分子脂质体精华液及其制备方法 |
CN116407459A (zh) * | 2023-05-15 | 2023-07-11 | 广州新妆生物科技有限公司 | 一种具有美白养颜抗辐射功能的精华及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105963153A (zh) | 包含蓝铜胜肽的活性组合物及化妆品或护肤品 | |
CN111481481B (zh) | 一种金丝皇菊纳米技术护肤品及其制备方法和应用 | |
EP3116599B1 (fr) | Utilisations cosmétiques de la swertiamarine | |
TW200423961A (en) | Composition for promoting production of type I collagen and/or elastin | |
CN107213069A (zh) | 一种美颜面膜及其制备方法 | |
CN113855581A (zh) | 一种多功能脂质体及其制备方法 | |
CN111265441A (zh) | 可增强皮肤夜间修复、再生能力的组合物及其应用 | |
CN113413332A (zh) | 一种具有美白抗氧化和修复功能的御米油脂质体 | |
KR20230152511A (ko) | 피부 트러블 완화 효과가 우수한 피부 재생용 화장료, 이의 제조방법 및 이를 포함하는 화장품 | |
KR102721819B1 (ko) | 녹차 뿌리 다당체를 함유하는 피부 보습 또는 피부 장벽 강화용 조성물 및 이의 제조방법 | |
KR102157210B1 (ko) | 천연 미생물 발효 흑삼 추출물을 포함하는 기능성 화장료 조성물 | |
KR20200083098A (ko) | 아세로라 추출물을 포함하는 리포좀을 함유하는 것을 특징으로 하는 화장료 조성물 | |
CN110613643A (zh) | 一种修复除皱霜及其制备方法 | |
KR101951816B1 (ko) | 월귤 열매 추출물을 흑효모 균사체로 발효한 월귤 열매 흑효모 발효액을 포함하는 화장료 조성물 | |
KR102801487B1 (ko) | 화장료 조성물 및 그 제조방법 | |
KR101724529B1 (ko) | 홍해삼 추출물을 흑효모 균사체로 발효한 홍해삼 흑효모 발효액을 포함하는 화장료 조성물 | |
CN109248125A (zh) | 一种含有蜂王浆提取物的天然滋润抗衰面膜 | |
KR20230135854A (ko) | 식물 복합추출물과 펩타이드 혼합물을 함유하는 피부 주름개선용 화장료 조성물 | |
KR100451387B1 (ko) | 피부 탄력 증가와 피부노화 억제 효과를 갖는 원지, 길경,병풀을 함유한 화장료 조성물 및 그 추출물 제조 방법 | |
KR20040091858A (ko) | 홍삼 및 죽여 혼합추출물을 함유하는 주름개선 및항스트레스성 화장료 조성물 | |
KR101855210B1 (ko) | 흑효모 발효 가지씨 초음파 추출물을 함유하는 화장료 조성물 | |
CN118948723B (zh) | 一种美白保湿面霜及其制备方法 | |
EP3052198A1 (fr) | Composition huileuse contenant un extrait d'hemerocalle et utilisations | |
KR102016641B1 (ko) | 포제 추출물을 포함하는 조성물 | |
CN113425637A (zh) | 一种针对儿童的红枸杞明目纳米眼霜及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210921 |
|
RJ01 | Rejection of invention patent application after publication |